Recent research points to semaglutide (the active drug in Ozempic and Wegovy) as a real option for shrinking liver fat in people living with HIV who develop metabolic dysfunction-associated steatotic liver disease, also called MASLD, or MASH when inflammation is present
Medications like Ozempic (semaglutide), Wegovy (higher dose of semaglutide), Mounjaro, and Zepbound (tirzepatide) mimic this hormone, sending signals to your brain that increase feelings of fullness and satisfaction
& Preedy, V.) 123 (Springer International Publishing, 2021)
The websites for both Ozempic and Wegovy state that the medications may harm unborn babies
And maintaining inflation during exhalation also decreases atelectrauma
"Synergistic Effect o Page 314 and 315: Menapace HM, Diaz N, and Weiss S